Disclosure Of Income Tax [Text Block]

OSE Immunotherapeutics - Filing #2813125

Concept	2022-01-01 to 2022-12-31	As at 2022-12-31	2021-01-01 to 2021-12-31	As at 2021-12-31
Disclosure of income tax [text block]	—	—	—	—
Major components of tax expense (income) [abstract]
Tax expense (income)	263,000 EUR	—	364,000 EUR	—
Disclosure of temporary difference, unused tax losses and unused tax credits [text block]	—	—	—	—
Disclosure of temporary difference, unused tax losses and unused tax credits [abstract]
Disclosure of temporary difference, unused tax losses and unused tax credits [line items]
Deferred tax assets and liabilities [abstract]
Deferred tax assets	—	182,000 EUR	—	173,000 EUR
Deferred tax liabilities	—	1 514 EUR	—	1 748 EUR
Reconciliation of accounting profit multiplied by applicable tax rates [abstract]